Abstract is: Michael S. Lauer is an American cardiologist and physician-scientist. He is the deputy director for extramural research at the National Institutes of Health (NIH).
| human | Q5 |
| P6178 | Dimensions author ID | 01105334575.49 |
| P2671 | Google Knowledge Graph ID | /g/11k2fkgq3j |
| P1960 | Google Scholar author ID | wFjiOFwAAAAJ |
| P1375 | NSK ID | 000324999 |
| P496 | ORCID iD | 0000-0002-9217-8177 |
| P3829 | Publons author ID | 2592322 |
| P1053 | ResearcherID | L-9656-2013 |
| P1153 | Scopus author ID | 7103183718 |
| P4012 | Semantic Scholar author ID | 2371803 |
| P10861 | Springer Nature person ID | 01105334575.49 |
| P214 | VIAF ID | 305643263 |
| P27 | country of citizenship | United States of America | Q30 |
| P69 | educated at | Albany Medical College | Q4709349 |
| P108 | employer | National Institutes of Health | Q390551 |
| Cleveland Clinic | Q4117596 | ||
| Lahey Clinic | Q6473221 | ||
| P734 | family name | Lauer | Q28150821 |
| Lauer | Q28150821 | ||
| Lauer | Q28150821 | ||
| P735 | given name | Michael | Q4927524 |
| Michael | Q4927524 | ||
| P106 | occupation | cardiologist | Q3264451 |
| physician-scientist | Q25141651 | ||
| P21 | sex or gender | male | Q6581097 |
| Q57072727 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q59356001 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary |
| Q57072732 | 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in Asymptomatic Adults: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q34154032 | 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines |
| Q35150530 | 34th Bethesda Conference: Task force #5--Is atherosclerosis imaging cost effective? |
| Q56928526 | ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 Expert Consensus Document on Coronary Computed Tomographic Angiography |
| Q37755896 | ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents |
| Q37761794 | ACCF/ACR/AHA/NASCI/SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents |
| Q58375412 | ACCF/AHA 2007 Clinical Expert Consensus Document on Coronary Artery Calcium Scoring by Computed Tomography in Global Cardiovascular Risk Assessment and in Evaluation of Patients With Chest Pain |
| Q34604622 | ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundat |
| Q28603731 | Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015 |
| Q35750181 | Advancing cardiovascular research. |
| Q82010700 | American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death. A scientific statement from the A |
| Q82198956 | American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the A |
| Q79632999 | American Heart Association/american College of Cardiology Foundation/heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the A |
| Q44127509 | An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram |
| Q71827437 | Angiographic and prognostic implications of an exaggerated exercise systolic blood pressure response and rest systolic blood pressure in adults undergoing evaluation for suspected coronary artery disease |
| Q81912251 | Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery |
| Q80441824 | Association of atheroma as assessed by intraoperative transoesophageal echocardiography with long-term mortality in patients undergoing cardiac surgery |
| Q78726263 | Association of educational status with heart rate recovery: a population-based propensity analysis |
| Q43901638 | Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. |
| Q82554343 | Association of socioeconomic status with functional capacity, heart rate recovery, and all-cause mortality |
| Q44816806 | Association of triglyceride-to-HDL cholesterol ratio with heart rate recovery |
| Q43815693 | Attenuation of rebound ischemia after discontinuation of heparin therapy by glycoprotein IIb/IIIa inhibition with eptifibatide in patients with acute coronary syndromes: observations from the platelet IIb/IIIa in unstable angina: receptor suppressio |
| Q42371483 | Basic science: Bedrock of progress |
| Q51936530 | Believability of clinical trials: a diagnostic testing perspective. |
| Q52519558 | Blunt traumatic rupture of a mitral papillary muscle head. |
| Q38380425 | COCATS 4 Task Force 15: Training in Cardiovascular Research and Scholarly Activity |
| Q53330520 | CT angiography: first things first. |
| Q81606480 | Can the ST segment be saved? |
| Q46039511 | Can we reliably predict long-term mortality after exercise testing? An external validation. |
| Q44689833 | Cardiac emergencies at a major international airport: A prospective observational study |
| Q81313693 | Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council |
| Q24289209 | Cardiovascular epidemiology in a changing world--challenges to investigators and the National Heart, Lung, and Blood Institute |
| Q45049107 | Caveat emptor: the treachery of work-up bias |
| Q40165151 | Chest pain on exercise treadmill test predicts future cardiac hospitalizations. |
| Q85588849 | Cholesterol Lowering in 2015: Still Answering Questions About How and in Whom |
| Q46777670 | Chronotropic incompetence as a predictor of death among patients with normal electrograms taking beta blockers (metoprolol or atenolol). |
| Q35290079 | Citation impact of NHLBI R01 grants funded through the American Recovery and Reinvestment Act as compared to R01 grants funded through a standard payline |
| Q56944385 | Clinical Trials—Multiple Treatments, Multiple End Points, and Multiple Lessons |
| Q83169393 | Clinical features of mixed physiology of constriction and restriction: echocardiographic characteristics and clinical outcome |
| Q96302243 | Combating sexual harassment |
| Q51372357 | Comparison of results of carotid stenting followed by open heart surgery versus combined carotid endarterectomy and open heart surgery (coronary bypass with or without another procedure). |
| Q57740318 | Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy |
| Q34615977 | Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond |
| Q112700981 | Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy |
| Q56944543 | Effect of anti-tumor necrosis factor-α polyclonal antibody on restenosis after balloon angioplasty in a rabbit atherosclerotic model |
| Q44825856 | Effect of exercise training in supervised cardiac rehabilitation programs on prognostic variables from the exercise tolerance test. |
| Q48625853 | Effect of functional health-related quality of life on long-term survival after cardiac surgery |
| Q43571946 | Effect of lipid-lowering therapy on early mortality after acute coronary syndromes: an observational study |
| Q42624972 | Electrocardiographic left ventricular hypertrophy in GUSTO IV ACS: an important risk marker of mortality in women |
| Q34999737 | Elements of danger--the case of medical imaging. |
| Q35968147 | Emerging cardiovascular risk factors that account for a significant portion of attributable mortality risk in chronic kidney disease. |
| Q38229371 | Engaging patients and stakeholders in research proposal review: the patient-centered outcomes research institute |
| Q56944813 | Evaluation of the effects of aspirin combined with angiotensin-converting enzyme inhibitors in patients with coronary artery disease |
| Q43436605 | Evidence-based medicine comes of age in pediatric cardiology. |
| Q33193493 | Exercise capacity: the prognostic variable that doesn't get enough respect |
| Q81546655 | External prognostic validations and comparisons of age- and gender-adjusted exercise capacity predictions |
| Q73049232 | Frequent ventricular ectopy after exercise as a predictor of death |
| Q36157290 | Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute |
| Q45216625 | Global risk scores and exercise testing for predicting all-cause mortality in a preventive medicine program |
| Q47644408 | Heart rate recovery after exercise is a predictor of mortality, independent of the angiographic severity of coronary disease |
| Q80908012 | Heart rate recovery and impact of myocardial revascularization on long-term mortality |
| Q84938072 | Heart rate recovery: what now? |
| Q46475932 | Heart rate response during dipyridamole stress as a predictor of mortality in patients with normal myocardial perfusion and normal electrocardiograms |
| Q37379321 | How one program at the National Heart, Lung, and Blood Institute establishes its scientific priorities |
| Q83663632 | How will exercise capacity gain enough respect? |
| Q37709948 | Identifying important risk factors for survival in patient with systolic heart failure using random survival forests |
| Q53056682 | Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. |
| Q76376060 | Impact of donor spontaneous intracranial hemorrhage on outcome after heart transplantation |
| Q80418445 | Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation |
| Q34380854 | Importance of treadmill exercise time as an initial prognostic screening tool in patients with systolic left ventricular dysfunction |
| Q51061743 | In unstable angina or non-ST-segment acute coronary syndrome, should patients with multivessel coronary artery disease undergo multivessel or culprit-only stenting? |
| Q47364159 | In-hospital initiation of lipid-lowering therapy after coronary intervention as a predictor of long-term utilization: a propensity analysis |
| Q40689430 | Incremental prognostic value of elevated baseline C-reactive protein among established markers of risk in percutaneous coronary intervention |
| Q113193910 | Inequalities in the distribution of National Institutes of Health research project grant funding |
| Q75403928 | Is systolic blood pressure recovery after exercise a predictor of mortality? |
| Q44535634 | Long-term prognostic value of peak oxygen consumption in women versus men with heart failure and severely impaired left ventricular systolic function |
| Q37727121 | Microvolt T-wave alternans, peak oxygen consumption, and outcome in patients with severely impaired left ventricular systolic function. |
| Q46877910 | Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction |
| Q42591123 | NHLBI Strategic Visioning: setting an agenda together for the NHLBI of 2025. |
| Q43216278 | NHLBI strategic visioning: setting an agenda together for the NHLBI of 2025. |
| Q38365751 | National Heart, Lung, and Blood Institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025. |
| Q86841014 | National Heart, Lung, and Blood Institute Strategic Visioning: setting an agenda together for the NHLBI of 2025 |
| Q97890473 | National Institutes of Health social and behavioral research in response to the SARS-CoV2 Pandemic |
| Q38388612 | National heart, lung, and blood institute (NHLBI) strategic visioning: setting an agenda together for the NHLBI of 2025. |
| Q28385820 | News from the NIH: potential contributions of the behavioral and social sciences to the precision medicine initiative |
| Q84790687 | On the value of portfolio diversity in heart, lung, and blood research |
| Q84872895 | On the value of portfolio diversity in heart, lung, and blood research |
| Q42406656 | On the value of portfolio diversity in heart, lung, and blood research |
| Q46034859 | Opinion: The Next Generation Researchers Initiative at NIH. |
| Q44320783 | Outcome of patients who refuse transfusion after cardiac surgery: a natural experiment with severe blood conservation |
| Q37465140 | Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute |
| Q37335877 | Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. |
| Q51806504 | Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. |
| Q51821422 | Outcomes research in cardiovascular imaging: report of a workshop sponsored by the National Heart, Lung, and Blood Institute. |
| Q42717224 | PCORnet: turning a dream into reality |
| Q44244793 | Peak oxygen consumption as a predictor of death in patients with heart failure receiving beta-blockers |
| Q26967626 | Percentile ranking and citation impact of a large cohort of National Heart, Lung, and Blood Institute-funded cardiovascular R01 grants |
| Q42371470 | Policy: NIH push to stop sexual harassment |
| Q43062317 | Power of the Cluster |
| Q24040334 | Predicting Productivity Returns on Investment: Thirty Years of Peer Review, Grant Funding, and Publication of Highly Cited Papers at the National Heart, Lung, and Blood Institute |
| Q40426324 | Prediction of death or myocardial infarction by exercise single photon emission computed tomography perfusion scintigraphy in patients who have had recent coronary artery stenting. |
| Q80507983 | Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial |
| Q56944125 | Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery |
| Q56944455 | Preprocedural white blood cell count and death after percutaneous coronary intervention |
| Q26967625 | Prior publication productivity, grant percentile ranking, and topic-normalized citation impact of NHLBI cardiovascular R01 grants |
| Q67566709 | Prognostic implications of subclinical left ventricular dilatation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study) |
| Q32076709 | Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy |
| Q80591461 | Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease |
| Q44304953 | Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4,728 patients. |
| Q40615288 | Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B). |
| Q51681449 | Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features. |
| Q34425217 | Quantitative electrocardiographic measures and long-term mortality in exercise test patients with clinically normal resting electrocardiograms |
| Q34987928 | Quantitative electrocardiography for predicting postoperative atrial fibrillation after cardiac surgery |
| Q39807458 | Quantitative measures of electrocardiographic left ventricular mass, conduction, and repolarization, and long-term survival after coronary artery bypass grafting |
| Q60921236 | Random survival forests |
| Q44420387 | Receptor for AGE (RAGE) mediates neointimal formation in response to arterial injury |
| Q38115766 | Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute |
| Q38148922 | Refocusing the agenda on cardiovascular guidelines: an announcement from the National Heart, Lung, and Blood Institute |
| Q46305706 | Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction |
| Q42412948 | Reply: "What if . . . the National Heart, Lung, and Blood Institute Considers Tobacco?" and "Smoking Control Is a Priority to Promote Heart, Lung, Blood, and Sleep Health" |
| Q94016221 | Response |
| Q37009560 | Rigorous science as the road to better public health |
| Q44035527 | Routine statin treatment after acute coronary syndromes? |
| Q56944331 | ST-segment resolution 60 minutes after combination treatment of abciximab with reteplase or reteplase alone for acute myocardial infarction (30-day mortality results from the resolution of ST-segment after reperfusion therapy substudy) |
| Q35562157 | Screening for left ventricular systolic dysfunction among patients with risk factors for heart failure |
| Q80456353 | Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure |
| Q40291656 | Short- and long-term risk stratification in acute coronary syndromes: the added value of quantitative ST-segment depression and multiple biomarkers |
| Q43960931 | Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction |
| Q43961868 | The "exercise" part of exercise echocardiography |
| Q37727126 | The Extramural Division of Cardiovascular Sciences of the National Heart, Lung, and Blood Institute |
| Q34113976 | The Scientific Foundation for personal genomics: recommendations from a National Institutes of Health-Centers for Disease Control and Prevention multidisciplinary workshop |
| Q56945181 | The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions |
| Q53066782 | The historical and moral imperatives of comparative effectiveness research |
| Q44385161 | The prognostic value of a nomogram for exercise capacity in women |
| Q44158707 | The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure |
| Q38001037 | The role of comparative effectiveness research in transfusion medicine clinical trials: proceedings of a National Heart, Lung, and Blood Institute workshop |
| Q56944486 | The rudimentary phase of personalised medicine: coronary risk scores |
| Q53978010 | The socio-geography of heart failure: why it matters. |
| Q51055208 | Thought exercises on accountability and performance measures at the National Heart, Lung, and Blood Institute (NHLBI): an invited commentary for circulation research. |
| Q28596867 | Time for a prepublication culture in clinical research? |
| Q90840631 | Topic choice contributes to the lower rate of NIH awards to African-American/black scientists |
| Q27205111 | Toward a New Era of Trust and Transparency in Clinical Trials |
| Q24289006 | Transforming Epidemiology for 21st Century Medicine and Public Health |
| Q48013743 | Transforming Evidence Generation to Support Health and Health Care Decisions |
| Q28193293 | Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction |
| Q37486205 | Use of hundreds of electrocardiographic biomarkers for prediction of mortality in postmenopausal women: the Women's Health Initiative. |
| Q73158403 | Use of segmental tissue Doppler velocity to quantitate exercise echocardiography |
| Q30711157 | Use of the logical analysis of data method for assessing long-term mortality risk after exercise electrocardiography |
| Q40525042 | Usefulness of plasma brain natriuretic peptide levels in predicting dobutamine-induced myocardial ischemia |
| Q80375677 | Usefulness of tissue doppler and color M-mode indexes of left ventricular diastolic function in predicting outcomes in systolic left ventricular heart failure (from the ADEPT study) |
| Q50689593 | Using science to improve the nation's health system: NIH's commitment to comparative effectiveness research. |
| Q78816248 | Value of exercise capacity and heart rate recovery in older people |
| Q79622561 | [18F]Fluorodeoxyglucose uptake by positron emission tomography for diagnosis of suspected lung cancer: impact of verification bias |
| Category:Michael Lauer | wikimedia | |
| Michael Lauer | wikipedia |
Search more.